Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia

Journal of Urology

Volumn 158, Issue 6, 1997, Pages 2188-2192

  Haese, Alexander ^a   Graefen, Markus ^a   Noldus, Joachim ^a   Hammerer, Peter ^a   Huland, Edith ^a   Huland, Hartwig ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Prostate specific antigen; Prostatic hypertrophy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030727290     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)68192-8     Document Type: Article

References (17)

1. Estève, J., Kricker, A., Ferlay, J. and Parkin, D. M.: Facts and Figures of Cancer in the European Community. Lyon, France: International Agency for Research on Cancer, p. 1, 1993.
2. Hara, M., Inorre, T. and Fukuyama, T.: Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma. Jap. J. Legal Med., 25: 322, 1971.
3. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159, 1979.
4. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
5. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
6. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
7. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., 147: 817, 1992.
8. Carter, H. B., Pearson, J. D., Metter, I. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, F. L. and Walsh, P. C.: Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
9. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
10. Chu, T. M., Kuriyama, M., Johnson, E., Papsideo, L. D., Killian, C. S. and Wang, M. C.: Circulating antibody to prostate antigen in patients with prostatic cancer. Ann. N.Y. Acad. Sci., 417: 383, 1983.
11. Lilja, H., Christensson, A., Dahlén, U., Matikainen, M.-T., Nilsson, O., Pettersson, K. and Lövgren, T.: Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin. Chem., 37: 1618, 1991.
12. Christensson, A., Björk, T., Nilsson, O., Dahlén, U., Matikainen, M.-T., Cockett, A. T. K., Abrahamsson, P.-A. and Lilja, H.: Serum prostate specific antigen complexed to α-1-antichymotrypsin as an indicator for prostate cancer. J. Urol., 150: 100, 1993.
13. Stenman, U. H., Leinonen, J., Alfthan, H., Ranniko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alpha-1-antitrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
14. Prestigiacomo, A. F., Lilja, H., Petterson, K., Wolfert, R. L. and Stamey, T. A.: A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J. Urol., 156: 350, 1996.
15. Elgamal, A.-A. A., Cornillie, F. J., Van Poppel, H. P., Van de Voorde, W. M., McCabe, R. and Baert, L. V.: Free-to-total prostate-specific antigen ratio as a single test for detection of significant stage T1c prostate cancer. J. Urol., 156: 1042, 1996.
16. Hammerer, P., Graefen, M., Noldus, J. and Huland, H.: Verbesserung des Spezifität des PSA-wertes dusch Bestimmung des freicu PSA-Auteiles in diagnostischen Graubercid. Urologe A, suppl., 35: 82, 1996.
17. Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S. and Schmid, H.-P.: Relationship of clinical significance for treatment to tumor volume in prostate cancer. National Conference on Prostate Cancer. American Cancer Society, 1992.